Analyst consensus rating
Bioventus Inc. - Class A Common Stock Analyst Consensus Rating
BVS analyst consensus rating, coverage count and price target evidence.
Direct answer
Bioventus Inc. - Class A Common Stock's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $16.80.
Forecast evidence checked August 12, 2026.
Get free Bioventus Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.69
- Average price target
- $16.80
- High price target
- $18.00
- Low price target
- $15.00
- Target upside
- +22.7%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026